Dr. Mario Otto, UW Health pediatric hematology and oncology, explains our new phase 1 immunotherapy clinical trial for children and adolescents with relapsed/refractory leukemias and solid tumors. The trial combines a graft-engineered haploidentical stem cell transplant with post-transplant immunotherapy to boost graft-versus-tumor effects and eradicate residual cancer cells.
![[Ep. 11] Understand SDL Event with Mouse motion, key presses, keycodes and scancodes | Intro to SDL2](https://i.ytimg.com/vi/EBHmMmiVtCk/mqdefault.jpg)
